Total Payments
$75,905
2024 Payments
$66,984
Companies
10
Transactions
69
Medicare Patients
3,013
Medicare Billing
$541,408
Payment Breakdown by Category
Consulting$39,198 (51.6%)
Travel$16,837 (22.2%)
Other$14,592 (19.2%)
Food & Beverage$5,279 (7.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $39,198 | 9 | 51.6% |
| Travel and Lodging | $16,837 | 16 | 22.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,592 | 4 | 19.2% |
| Food and Beverage | $5,279 | 40 | 7.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $30,989 | 27 | $0 (2024) |
| GE HEALTHCARE | $30,170 | 12 | $0 (2024) |
| Olea Medical | $9,795 | 4 | $0 (2024) |
| GUERBET LLC | $3,113 | 9 | $0 (2023) |
| Viz.ai, Inc. | $724.55 | 5 | $0 (2022) |
| Siemens Medical Solutions USA, Inc. | $650.75 | 5 | $0 (2024) |
| FUJIFILM Healthcare Americas Corporation | $128.71 | 1 | $0 (2023) |
| Vertiflex, Inc. | $124.60 | 1 | $0 (2019) |
| Lilly USA, LLC | $115.00 | 1 | $0 (2017) |
| Boston Scientific Corporation | $94.79 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $66,984 | 36 | Eisai Inc. ($30,989) |
| 2023 | $2,999 | 10 | Olea Medical ($1,963) |
| 2022 | $5,390 | 15 | GUERBET LLC ($2,536) |
| 2021 | $50.33 | 1 | GE HEALTHCARE ($50.33) |
| 2019 | $124.60 | 1 | Vertiflex, Inc. ($124.60) |
| 2018 | $200.53 | 3 | GE Healthcare ($182.71) |
| 2017 | $156.25 | 3 | Lilly USA, LLC ($115.00) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Eisai Inc. | Leqembi (Drug) | Consulting Fee | Cash or cash equivalent | $4,042.50 | General |
| Category: Neurology | ||||||
| 12/27/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $656.77 | General |
| Category: Neurology | ||||||
| 12/27/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $72.77 | General |
| Category: Neurology | ||||||
| 12/27/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $51.50 | General |
| Category: Neurology | ||||||
| 12/27/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $13.98 | General |
| Category: Neurology | ||||||
| 11/14/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $136.24 | General |
| 11/13/2024 | Eisai Inc. | Leqembi (Drug) | Consulting Fee | Cash or cash equivalent | $4,410.00 | General |
| Category: Neurology | ||||||
| 11/11/2024 | GE HEALTHCARE | Vizamyl (Drug) | Travel and Lodging | In-kind items and services | $2,136.00 | General |
| Category: Pharma Imaging Agents - Nuclear Imaging | ||||||
| 11/08/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: Neurology | ||||||
| 11/08/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: Neurology | ||||||
| 11/08/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Neurology | ||||||
| 11/08/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Neurology | ||||||
| 10/16/2024 | GE HEALTHCARE | Clariscan (Drug) | Consulting Fee | Cash or cash equivalent | $12,780.00 | General |
| Category: Pharma Imaging Agents - Contrast Media | ||||||
| 09/17/2024 | Eisai Inc. | Leqembi (Drug) | Consulting Fee | Cash or cash equivalent | $5,880.00 | General |
| Category: Neurology | ||||||
| 09/17/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $5,880.00 | General |
| Category: Neurology | ||||||
| 09/17/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $580.16 | General |
| Category: Neurology | ||||||
| 09/17/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $390.40 | General |
| Category: Neurology | ||||||
| 09/17/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $200.00 | General |
| Category: Neurology | ||||||
| 09/17/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $100.00 | General |
| Category: Neurology | ||||||
| 09/17/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $71.14 | General |
| Category: Neurology | ||||||
| 09/17/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $64.59 | General |
| Category: Neurology | ||||||
| 09/17/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $59.91 | General |
| Category: Neurology | ||||||
| 09/17/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $27.00 | General |
| Category: Neurology | ||||||
| 08/14/2024 | Eisai Inc. | Leqembi (Drug) | Consulting Fee | Cash or cash equivalent | $735.00 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $121.78 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 575 | 15,141 | $604,992 | $96,090 |
| 2022 | 12 | 693 | 17,538 | $718,517 | $115,150 |
| 2021 | 16 | 1,063 | 27,502 | $1.1M | $184,599 |
| 2020 | 13 | 682 | 11,072 | $706,734 | $145,569 |
Total Patients
3,013
Total Services
71,253
Medicare Billing
$541,408
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 84 | 86 | $141,900 | $21,824 | 15.4% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 108 | 108 | $117,672 | $18,870 | 16.0% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 102 | 102 | $127,602 | $17,799 | 13.9% |
| 70543 | Mri scan of bone of eye socket, face, and/or neck before and after contrast | Office | 2023 | 47 | 48 | $79,104 | $15,691 | 19.8% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 39 | 39 | $42,058 | $6,124 | 14.6% |
| 70544 | Mri scan of blood vessels of head without contrast | Office | 2023 | 27 | 27 | $32,643 | $5,264 | 16.1% |
| 70547 | Mri scan of blood vessels of neck without contrast | Office | 2023 | 14 | 14 | $16,926 | $2,864 | 16.9% |
| 70450 | Ct scan head or brain without contrast | Office | 2023 | 27 | 27 | $13,041 | $2,438 | 18.7% |
| 72146 | Mri scan of middle spinal canal without contrast | Office | 2023 | 16 | 16 | $17,109 | $2,046 | 12.0% |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | Office | 2023 | 97 | 14,660 | $8,796 | $1,643 | 18.7% |
| 72131 | Ct scan of lower spine without contrast | Office | 2023 | 14 | 14 | $8,141 | $1,525 | 18.7% |
| 70551 | Mri scan of brain without contrast | Office | 2022 | 140 | 143 | $178,893 | $25,652 | 14.3% |
| 70553 | Mri scan of brain before and after contrast | Office | 2022 | 92 | 93 | $153,450 | $23,865 | 15.6% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2022 | 103 | 105 | $116,130 | $18,297 | 15.8% |
| 70543 | Mri scan of bone of eye socket, face, and/or neck before and after contrast | Office | 2022 | 44 | 45 | $74,160 | $15,077 | 20.3% |
| 70544 | Mri scan of blood vessels of head without contrast | Office | 2022 | 41 | 41 | $49,569 | $8,083 | 16.3% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2022 | 42 | 43 | $48,332 | $7,170 | 14.8% |
| 70547 | Mri scan of blood vessels of neck without contrast | Office | 2022 | 27 | 27 | $32,643 | $5,642 | 17.3% |
| 70450 | Ct scan head or brain without contrast | Office | 2022 | 34 | 34 | $16,062 | $3,273 | 20.4% |
| 72146 | Mri scan of middle spinal canal without contrast | Office | 2022 | 21 | 22 | $24,750 | $2,938 | 11.9% |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | Office | 2022 | 110 | 16,946 | $10,168 | $1,948 | 19.2% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Office | 2022 | 25 | 25 | $5,750 | $1,682 | 29.3% |
| 72131 | Ct scan of lower spine without contrast | Office | 2022 | 14 | 14 | $8,610 | $1,523 | 17.7% |
| 70553 | Mri scan of brain before and after contrast | Office | 2021 | 132 | 137 | $226,050 | $36,193 | 16.0% |
| 70551 | Mri scan brain | Office | 2021 | 173 | 174 | $217,674 | $33,218 | 15.3% |
About Dr. Suzanne Bash, MD
Dr. Suzanne Bash, MD is a Diagnostic Radiology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417998253.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Suzanne Bash, MD has received a total of $75,905 in payments from pharmaceutical and medical device companies, with $66,984 received in 2024. These payments were reported across 69 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($39,198).
As a Medicare-enrolled provider, Bash has provided services to 3,013 Medicare beneficiaries, totaling 71,253 services with total Medicare billing of $541,408. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Radiology
- Location Los Angeles, CA
- Active Since 06/10/2006
- Last Updated 12/04/2008
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1417998253
Products in Payments
- Leqembi (Drug) $30,989
- Vizamyl (Drug) $15,108
- Clariscan (Drug) $12,780
- ELUCIREM (Drug) $2,366
- Viz.AI LVO (Device) $724.55
- Elucirem (Drug) $501.29
- ECHELON OVAL (Device) $128.71
- Superion ISS (Device) $124.60
- AMYVID (Drug) $115.00
- MAGNETOM Vida (Device) $61.57
- SPECTRA IPG (Device) $41.25
- Varithena Administration Pack (Device) $35.72
- GENERAL - PAIN MANAGEMENT (Device) $17.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Los Angeles
Edward Lee, Md, MD
Diagnostic Radiology — Payments: $1.3M
Diagnostic Radiology $1.3M
Dr. John Moriarty, M.d. Mrcpi Ffr(Rcsi), M.D. MRCPI FFR(RCSI)
Diagnostic Radiology — Payments: $866,087
Diagnostic Radiology $866,087
Dr. Gary Ulaner, M.d. Ph.d, M.D. PH.D
Diagnostic Radiology — Payments: $560,607
Diagnostic Radiology $560,607
Mary Yamashita, Md, MD
Diagnostic Radiology — Payments: $359,279
Diagnostic Radiology $359,279
Dr. Arthur Baghdanian, Md, MD
Diagnostic Radiology — Payments: $270,314
Diagnostic Radiology $270,314
Jonathan Goldin, Md, MD
Diagnostic Radiology — Payments: $254,449
Diagnostic Radiology $254,449